DT Cloud Star Acquisition appoints Dr. Xunyong Zhou as director

DT Cloud Star Acquisition Corp (NASDAQ:DTSQ) announced that its board of directors appointed Dr. Xunyong Zhou as a director of the company on Wednesday. The information is based on a press release statement included in a recent SEC filing. The SPAC, currently trading at $16.45 per unit under the symbol DTSQU, has a market capitalization of approximately $96 million according to InvestingPro data.

Dr. Zhou, age 50, has over six years of experience in biotechnology and health innovation, with a focus on enzyme-based theory for food products, cosmetics, daily chemicals, and tea. He holds more than 20 patents and has served as director for Huakang Biomedical Holdings Company Limited (HK:08622) since November 2025.

Since January 2023, Dr. Zhou has been chairman of Nanjing Hezhen Holding Group Co., Ltd., where he leads advancements in biological enzyme solutions and cell therapy technologies. He is also responsible for integrating healthcare generative pre-training transformer and enzyme therapy expertise to develop a collaborative platform for health solutions.

Additionally, Dr. Zhou oversees Changsha Kerong Health Technology Co., Ltd., which provides AI-enhanced health education, consultation, and management services. From March 2019 to January 2023, he was chairman of Zhenzhen Suqian Biotechnology Co. Ltd.

Dr. Zhou graduated from Tianjin University with a bachelor’s degree in engineering, majoring in business administration in 2002, and from Fudan University with a master’s degree in law in 2011. He received a doctorate in business administration from Université Nice Sophia Antipolis in 2016. He is currently the honorary chairman of the Vaccine and Immune Health Branch of the Liaoning Immunology Society and a member of the National Enzyme Engineering and Fermentation Engineering Professional Committee.

DT Cloud Star Acquisition Corp is incorporated in the Cayman Islands and its ordinary shares, units, and rights are listed on The Nasdaq Stock Market under the symbols DTSQ, DTSQU, and DTSQR, respectively. Financial metrics from InvestingPro show the company trading at a P/E ratio of 36.83 with a basic EPS of $0.29 for the last twelve months. The company currently appears overvalued based on InvestingPro’s Fair Value assessment, with a financial health score rated as "FAIR." Investors seeking deeper insights into SPAC valuations can access additional ProTips and comprehensive financial metrics through an InvestingPro subscription.

In other recent news, DT Cloud Star Acquisition Corp has made several significant announcements. Shareholders have approved amendments to extend the deadline for completing a business combination, allowing the company to extend this period by up to nine months, with each extension requiring a $75,000 deposit into its trust account. Additionally, DT Cloud Star has entered into a non-redemption agreement with an unaffiliated third-party shareholder involving 600,000 ordinary shares. In exchange for not redeeming these shares, the shareholder will receive 200,000 ordinary shares upon the closing of the company’s initial business combination.

The company also announced the adjournment of its annual general meeting, setting new dates for October 20 and October 22, 2025. Shareholders have the opportunity to change or revoke their prior votes until the specified deadlines. Furthermore, DT Cloud Star has extended the deadline for shareholders to exercise their redemption rights. Shareholders who have submitted redemption requests may withdraw them by contacting VStock Transfer, LLC. These developments indicate active shareholder engagement and strategic maneuvers by DT Cloud Star Acquisition Corp.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.